MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'acute lymphoblastic leukemia'. Sat, 03 Sep 2011 02:59:18 +0100 http://www.medworm.com/index.php?rid=2984987&cid=t_145795_136_f&fid=37846&url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2009%2F11%2F11%2Fucla-researchers-significantly-inhibit-growth-of-ovarian-cancer-cell-lines-with-fda-approved-leukemia-drug-dasatinib-sprycel%25c2%25ae%2F The drug dasatinib (Sprycel®), approved for use by the U.S. Food and Drug Administration in patients with specific types of leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, say UCLA researchers in the November 10th issue of the British Journal of Cancer. The drug, when paired with [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=2984987 Thu, 12 Nov 2009 00:45:53 +0100 2984987 http://www.medworm.com/index.php?rid=1088870&cid=t_145795_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F199095375%2F The targeted cancer pill – Gleevec - has been approved for the treatment of gastrointestinal stromal tumors, pediatric CML, as well as five additional rare cancers. While it has been reported to have saved more than 100,000 lives, Gleevec is now saving more children with a dire leukemia (Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) ), as well as preventing disease progression with long term use in adults with chronic myeloid leukemia (CML). Such were the data reported by Oregon Health & Science University (OSHU) at the recent annual meeting of the American Society of Hematology: “Data at this weekend’s meeting continues to show how much Gleevec has completely changed the outlook for so many, many patients facing cancer. Researchers delivered news that G... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1088870 Wed, 12 Dec 2007 09:31:10 +0100 1088870 http://www.medworm.com/index.php?rid=1020091&cid=t_145795_136_f&fid=36051&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F183396354%2F According to a new study from St. Jude Children’s Research Hospital, the anti-leukemia drug dexamethasone contributes to a relentless fatigue and poor quality of sleep in children undergoing treatment for acute lymphoblastic leukemia (ALL) – thereby suggesting that clinicians could improve the quality of life for these children by developing new methods of drug administration that reduce or eliminate these side effects. Although effective in the treatment of ALL, dexamethasone could also cause a variety of side effects in children, including fatigue. The St. Jude team showed that dexamethasone significantly increased patients?fatigue, length of daytime naps, frequency of awakening at night and the amount of restlessness during sleep. The findings also suggest that before initia... Cancer Commentary blogs http://www.medworm.com/rss/comments.php?id=1020091 Mon, 12 Nov 2007 04:59:47 +0100 1020091 http://www.medworm.com/index.php?rid=853126&cid=t_145795_87_f&fid=34865&url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F09%2F09%2Fst-jude-finds-factors-that-indicate-resistance-in-acute-lymphob%2F Filed under: LeukemiaResults of a study at St. Jude show why imatinib (Gleevec) is unable to prevent the relapse of an aggressive form of acute lymphoblastic leukemia (ALL). Imatinib has improved the treatment of chronic myelogenous leukemia (CML) dramatically. CML and an aggressive form of ALL share the same mutation, the Philadelphia chromosome (Ph). Ph-postiive cells produce a growth-promoting enzyme BCR-ABL. However, in some aggressive cases of ALL, Ph-positive cells lack a tumor suppressor gene called Arf, which is present in CML cells, say the researchers. The paper's first author, Richard T. Williams, says that doctors might be able to identify those people with ALL who lack Arf.Permalink | Email this | Linking Blogs | Comments (Source: The Cancer ... The Cancer Blog blogs http://www.medworm.com/rss/comments.php?id=853126 Sun, 09 Sep 2007 04:00:00 +0100 853126